(ALCRB) Carbios - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0011648716
Enzymes, Recycling, Biodegradation
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 88.2% |
| Value at Risk 5%th | 120% |
| Relative Tail Risk | -17.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 51.20 |
| CAGR/Max DD | -0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.429 |
| Beta | 0.373 |
| Beta Downside | 0.353 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.77% |
| Mean DD | 51.31% |
| Median DD | 45.05% |
Description: ALCRB Carbios December 04, 2025
Carbios SAS, listed under the ticker ALCRB, is a French biotech firm founded in 2011 and based in Clermont-Ferrand. It focuses on designing and scaling enzymatic processes for plastic recycling and biodegradation, and it commercialises these technologies internationally.
Key recent indicators include a partnership with Nestlé announced in 2023 to develop large-scale PET-enzyme recycling facilities, with an initial plant capacity target of ~50,000 t/yr of recycled PET. The company raised €150 m in a 2022 equity round, reflecting investor confidence in its proprietary enzymes, while its cash burn remains a critical metric given the capital-intensive nature of plant construction. Sector-wide, tightening EU regulations on single-use plastics and the EU Circular Economy Action Plan are accelerating demand for enzymatic recycling solutions, positioning Carbios to benefit from policy-driven market growth.
For a deeper dive into Carbios’s valuation metrics and risk profile, check the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-70.2m TTM) > 0 and > 6% of Revenue (6% = 39.5k TTM) |
| FCFTA -0.55 (>2.0%) and ΔFCFTA -29.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9965 % (prev 86.3k%; Δ -76.4kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.25 (>3.0%) and CFO -59.7m > Net Income -70.2m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (16.9m) change vs 12m ago 49.48% (target <= -2.0% for YES) |
| Gross Margin 82.55% (prev 95.06%; Δ -12.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.31% (prev 0.05%; Δ 0.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -24.42 (EBITDA TTM -49.2m / Interest Expense TTM 2.85m) >= 6 (WARN >= 3) |
Altman Z'' -3.53
| (A) 0.27 = (Total Current Assets 88.8m - Total Current Liabilities 23.1m) / Total Assets 240.9m |
| (B) -0.45 = Retained Earnings (Balance) -107.8m / Total Assets 240.9m |
| (C) -0.33 = EBIT TTM -69.7m / Avg Total Assets 209.4m |
| (D) -1.55 = Book Value of Equity -101.3m / Total Liabilities 65.5m |
| Total Rating: -3.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 24.52
| 1. Piotroski 0.50pt |
| 2. FCF Yield -83.95% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 0.55 |
| 6. ROIC - WACC (= -33.75)% |
| 7. RoE -33.96% |
| 8. Rev. Trend -32.49% |
| 9. EPS Trend -65.77% |
What is the price of ALCRB shares?
As of December 24, 2025, the stock is trading at EUR 10.93 with a total of 23,547 shares traded.
Over the past week, the price has changed by -5.37%, over one month by +27.99%, over three months by +11.25% and over the past year by +56.14%.
Over the past week, the price has changed by -5.37%, over one month by +27.99%, over three months by +11.25% and over the past year by +56.14%.
Is ALCRB a buy, sell or hold?
Carbios has no consensus analysts rating.
What are the forecasts/targets for the ALCRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 9.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10 | -8.7% |
ALCRB Fundamental Data Overview December 24, 2025
Market Cap USD = 216.0m (184.5m EUR * 1.171 EUR.USD)
Market Cap EUR = 184.5m (184.5m EUR * 1.0 EUR.EUR)
P/S = 316.9543
P/B = 1.0805
Beta = 1.601
Revenue TTM = 659.0k EUR
EBIT TTM = -69.7m EUR
EBITDA TTM = -49.2m EUR
Long Term Debt = 31.2m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 4.66m EUR (from shortTermDebt, last quarter)
Debt = 44.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -26.8m EUR (from netDebt column, last quarter)
Enterprise Value = 157.6m EUR (184.5m + Debt 44.9m - CCE 71.7m)
Interest Coverage Ratio = -24.42 (Ebit TTM -69.7m / Interest Expense TTM 2.85m)
FCF Yield = -83.95% (FCF TTM -132.3m / Enterprise Value 157.6m)
FCF Margin = -20.1k% (FCF TTM -132.3m / Revenue TTM 659.0k)
Net Margin = -10.7k% (Net Income TTM -70.2m / Revenue TTM 659.0k)
Gross Margin = 82.55% ((Revenue TTM 659.0k - Cost of Revenue TTM 115.0k) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 36.51%)
Tobins Q-Ratio = 0.65 (Enterprise Value 157.6m / Total Assets 240.9m)
Interest Expense / Debt = 0.95% (Interest Expense 426.0k / Debt 44.9m)
Taxrate = -0.0% (0.0 / -33.1m)
NOPAT = -69.7m (EBIT -69.7m * (1 - -0.00%)) [loss with tax shield]
Current Ratio = 3.84 (Total Current Assets 88.8m / Total Current Liabilities 23.1m)
Debt / Equity = 0.26 (Debt 44.9m / totalStockholderEquity, last quarter 175.4m)
Debt / EBITDA = 0.55 (negative EBITDA) (Net Debt -26.8m / EBITDA -49.2m)
Debt / FCF = 0.20 (negative FCF - burning cash) (Net Debt -26.8m / FCF TTM -132.3m)
Total Stockholder Equity = 206.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -29.14% (Net Income -70.2m / Total Assets 240.9m)
RoE = -33.96% (Net Income TTM -70.2m / Total Stockholder Equity 206.7m)
RoCE = -29.28% (EBIT -69.7m / Capital Employed (Equity 206.7m + L.T.Debt 31.2m))
RoIC = -27.62% (negative operating profit) (NOPAT -69.7m / Invested Capital 252.2m)
WACC = 6.13% (E(184.5m)/V(229.3m) * Re(7.39%) + D(44.9m)/V(229.3m) * Rd(0.95%) * (1-Tc(-0.0)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 22.26%
Fair Price DCF = unknown (Cash Flow -132.3m)
EPS Correlation: -65.77 | EPS CAGR: -79.53% | SUE: N/A | # QB: 0
Revenue Correlation: -32.49 | Revenue CAGR: -16.47% | SUE: -0.44 | # QB: 0
EPS next Year (2026-12-31): EPS=-1.48 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+28.8% | Growth Revenue=+457.1%
Market Cap EUR = 184.5m (184.5m EUR * 1.0 EUR.EUR)
P/S = 316.9543
P/B = 1.0805
Beta = 1.601
Revenue TTM = 659.0k EUR
EBIT TTM = -69.7m EUR
EBITDA TTM = -49.2m EUR
Long Term Debt = 31.2m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 4.66m EUR (from shortTermDebt, last quarter)
Debt = 44.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -26.8m EUR (from netDebt column, last quarter)
Enterprise Value = 157.6m EUR (184.5m + Debt 44.9m - CCE 71.7m)
Interest Coverage Ratio = -24.42 (Ebit TTM -69.7m / Interest Expense TTM 2.85m)
FCF Yield = -83.95% (FCF TTM -132.3m / Enterprise Value 157.6m)
FCF Margin = -20.1k% (FCF TTM -132.3m / Revenue TTM 659.0k)
Net Margin = -10.7k% (Net Income TTM -70.2m / Revenue TTM 659.0k)
Gross Margin = 82.55% ((Revenue TTM 659.0k - Cost of Revenue TTM 115.0k) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 36.51%)
Tobins Q-Ratio = 0.65 (Enterprise Value 157.6m / Total Assets 240.9m)
Interest Expense / Debt = 0.95% (Interest Expense 426.0k / Debt 44.9m)
Taxrate = -0.0% (0.0 / -33.1m)
NOPAT = -69.7m (EBIT -69.7m * (1 - -0.00%)) [loss with tax shield]
Current Ratio = 3.84 (Total Current Assets 88.8m / Total Current Liabilities 23.1m)
Debt / Equity = 0.26 (Debt 44.9m / totalStockholderEquity, last quarter 175.4m)
Debt / EBITDA = 0.55 (negative EBITDA) (Net Debt -26.8m / EBITDA -49.2m)
Debt / FCF = 0.20 (negative FCF - burning cash) (Net Debt -26.8m / FCF TTM -132.3m)
Total Stockholder Equity = 206.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -29.14% (Net Income -70.2m / Total Assets 240.9m)
RoE = -33.96% (Net Income TTM -70.2m / Total Stockholder Equity 206.7m)
RoCE = -29.28% (EBIT -69.7m / Capital Employed (Equity 206.7m + L.T.Debt 31.2m))
RoIC = -27.62% (negative operating profit) (NOPAT -69.7m / Invested Capital 252.2m)
WACC = 6.13% (E(184.5m)/V(229.3m) * Re(7.39%) + D(44.9m)/V(229.3m) * Rd(0.95%) * (1-Tc(-0.0)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 22.26%
Fair Price DCF = unknown (Cash Flow -132.3m)
EPS Correlation: -65.77 | EPS CAGR: -79.53% | SUE: N/A | # QB: 0
Revenue Correlation: -32.49 | Revenue CAGR: -16.47% | SUE: -0.44 | # QB: 0
EPS next Year (2026-12-31): EPS=-1.48 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+28.8% | Growth Revenue=+457.1%